Induction of antinuclear antibody after interferon therapy in patients with type-C chronic hepatitis: Its relation to the efficacy of therapy

Scandinavian Journal of Gastroenterology

Volumn 31, Issue 7, 1996, Pages 716-722

  Noda, K ^a   Enomoto, N ^a   Aral, K ^a   Masuda, E ^a   Yamada, Y ^a   Suzuki, K ^a   Tanaka, M ^a   Yoshihara, H ^a  

^a OSAKA ROSAI HOSPITAL   (Japan)

Author keywords

Antinuclear antibody; chronic hepatitis C; interferon therapy

Indexed keywords

ALPHA INTERFERON; ANTINUCLEAR ANTIBODY;

ADULT; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SCREENING; FEMALE; HEPATITIS C; HUMAN; IMMUNOTHERAPY; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL;

EID: 0029778920     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365529609009156     Document Type: Article

References (30)

1. Mishiro S, Hoshi Y, Takeda K, Yoshikawa A, Gotanda T, Takahashi K, et al. Non A nonB hepatitis specific antibodies directed at host-derived epitope: implication for an autoimmune process. Lancet 1990;336:1400-3.
2. Lenzi M, Ballaraini G, Fusconi M, Cassani F, Selleri L, Volta U, et al. Type 2 autoimmune hepatitis and hepatitis C infection. Lancet 1990;335:258-9.
3. Pawlotsky JM, Deforges L, Bretagne S, André C, Métreau JM, Thiers V, et al. Hepatitis C virus infection can mimic type 1 (antinuclear antibody positive) autoimmune chronic active hepatitis. Gut 1993;Suppl:S66-8.
4. Kiyosawa K, Seki T, Tanaka E, Sodeyama T, Furuta K, Furuta S, et al. Comparison of the immunogenetic features between patients with autoimmune hepatitis and patients with type C chronic active hepatitis. Gastroenterol Jpn 1993;28:63-8.
5. Meyet WJ, Hess G, Gerken G, Rossol S, Voth R, Manns M, et al. Treatment of chronic type B hepatitis with recombinant alfa interferon induces autoantibody not specific for autoimmune chronic hepatitis. Hepatology 1989;10:24-8.
6. Saracco G, Touscoz A, Durazzo M, Rosina F, Donegani E, Chiandussi L, et al. Autoantibodies and response to α-interferon in patients with chronic viral hepatitis. J Hepatol 1990;11: 339-43.
7. Fattovich G, Betterle C, Brollo L, Pedini L, Guistina G, Realdi G, et al. Autoantibodies during α-interferon therapy for chronichepatitis. Br J Med Virol 1991;34:132-5.
8. Fried MW, Draguesku JO, Shindo M, Simpson LH, Steven MB, Hoofnagle JH, et al. Clinical and serological differentiation of autoimmune and hepatitis C virus-related chronic hepatitis. Dig Dis Sci 1993;4:631-6.
9. Fridman WH, Gresser I, Bandu MT, Aguet M, Neauport-Sautes C. Interferon enhances the expression of Fc γ receptors. J Immunol 1980;5:2436-41.
10. Itoh K, Inoue M, Kataoka S, Kumagami K. Differential effect of interferon expression of IgG- and IgM-Fc receptors on human lymphocyte. J Immunol 1980;6:2589-95.
11. Rhodes J, Jones DH, Blechen NM. Increased expression of human monocyte HLA-DR antigens and Fc γ receptors in response to interferon in vivo. Clin Exp Immunol 1983;53: 739-43.
12. Schattner A. Interferons and autoimmunity. Am J Med Sci 1998;295:532-44.
13. Vento S, Perri GD, Garofano T, Cosco L, Conica E, Ferraro T, et al. Hazards of interferon therapy for HBV-seronegative chronic hepatitis. Lancet 1989;2:926.
14. Shindo M, Bisceglie AMD, Hoofnagle JH. Acute exacerbation of liver disease during interferon alfa therapy for chronic hepatitis C. Gastroenterology 1992;102:1406-8.
15. Silva MO, Reddy KR, Jeffers LJ, Hill M, Schiff ER. Interferoninduced chronic active hepatitis? Gastroenterology 1991;101: 840-2.
16. Marcellin P, Pouteau M, Renard P, Grynblat JM, Colas Linhart N, Bordet P, et al. Sustained hypothyroidism induced by recombinant α interferon in patients with chronic hepatitis C. Gut 1992;33:855-6.
17. Hirohata S, Inoue T, Ito K. Development of rheumatoid arthritis after chronic hepatitis caused by hepatitis C virus infection. Int Med 1992;31:493-5.
18. Conlon KC, Uraba WJ, Smith JW II, Steis RG, Longo DL, Clark JW. Exacerbation of symptoms of autoimmune disease in patients receiving alfa-interferon therapy. Cancer 1990;65: 2237-42.
19. Clifford BD, Donahue D, Smith L, Cable E, Luttig B, Manns M, et al. High prevalences of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology 1995;21:613-9.
20. Osada K, Sameshima Y, Fujii H, Shimizu M, Watanabe J, Nishioka K. Effect of blood screening for anti-HCV antibody by the second-generation passive hemagglutination test on the incidence of post-transfusion hepatitis. In: Nishioka K, editor. Viral hepatitis and liver disease. Hong Kong: Springer-Verlag, 1994:562-4.
21. Ulrich PP, Romeo JM, Lane PK, Kelly I, Daniel LJ, Vyas GN. Detection, semiquantitation, and genetic variation in hepatitis C virus sequence amplified from the plasma of blood donors with elevated alanine aminotransferase. J Clin Invest 1990;86: 1609-14.
22. Johnson PJ, McFarlane IG. Meeting report: international autoimmune hepatitis group. Hepatology 1993;18:998-1005.
23. Hagiwara H, Hayashi N, Mita E, Takehara T, Kasahara A, Fusamoto H, et al. Quantitative analysis of hepatitis C virus RNA in serum during interferon alfa therapy. Gastroenterology 1993;104:877-83.
24. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 1992;73:673-9.
25. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic hepatitis. Hepatology 1981;1:431-5.
26. Robertson DA, Zhang SL, Guy EC, Wright R. Persistent measles virus genome in autoimmune chronic active hepatitis. Lancet 1987;2:9-11.
27. Estehan JI, Esteban R, Viladomiu L, Lopez Talavera JC, Gonzalez A, Hernandez JM, et al. Hepatitis C virus antibodies among risk groups in Spain. Lancet 1989;2:294-7.
28. McFarlane IG, Smith HM, Johnson PJ, Bray GP, Vergani D, Williams R, et al. Hepatitis C virus antibodies in chronic active hepatitis: pathogenic factor or false positive result? Lancet 1990;335:754-57.
29. Ikeda Y, Toda G, Hashimoto N, Kurokawa K. Antibody to Superoxide dismutase, autoimmune hepatitis, and antibody for hepatitis C virus. Lancet 1990;335:1345-6.
30. Nishiguchi S, Kuroki T, Ueda T, Fukuda K, Takeda T, Nakajima S, et al. Detection of hepatitis C virus antibody in the absence of viral RNA in patients with autoimmune hepatitis. Ann Intern Med 1992;116:21-5.